Pathophysiological and clinical approach to cirrhotic cardiomyopathy

Alida Páll1, Arpád Czifra1, Zsuzsanna Vitális1

  • 1University of Debrecen Clinical Center, Institute of Medicine, Department of Gastroenterology, Debrecen, Hungary.

Insights

Cirrhotic cardiomyopathy (CCM) involves heart dysfunction in cirrhosis patients, but it can improve with treatment or liver transplant. Echocardiography and electrocardiography are key for diagnosing CCM and its cardiac abnormalities.

Area of Science:

  • Cardiology
  • Hepatology
  • Internal Medicine

Background:

  • Cirrhosis is linked to hyperdynamic circulation, systolic/diastolic left ventricular dysfunction, and electrophysiological abnormalities.
  • These cardiac issues define cirrhotic cardiomyopathy (CCM), marked by reduced myocardial contractile response to stress.
  • CCM-related cardiac dysfunction is potentially reversible with treatment or liver transplantation.

Purpose of the Study:

  • To review the pathophysiology and clinical features of cirrhotic cardiomyopathy (CCM).
  • To summarize current diagnostic and treatment strategies for this cardio-hepatic disorder.

Main Methods:

  • Review of existing literature on cirrhotic cardiomyopathy.
  • Analysis of diagnostic tools including echocardiography, electrocardiography, and laboratory markers.

Main Results:

  • CCM presents with specific cardiac functional and electrophysiological changes.
  • Echocardiography and electrocardiography are crucial for diagnosis.
  • Laboratory markers serve as auxiliary diagnostic aids.

Conclusions:

  • Understanding CCM pathophysiology is vital for effective management.
  • Early diagnosis and treatment can improve cardiac function in cirrhosis patients.
  • Liver transplantation offers a potential therapeutic option for reversing CCM.

Related Concept Videos

Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
809
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
743
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to...
26
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
795
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
767
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
23